Sagent Pharmaceuticals (SGNT)

Add to Watchlists Create an Alert
17.95 +0.64  +3.70%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Sagent Pharmaceuticals Gross Profit Margin Quarterly:

30.66% for March 31, 2013
View Full Chart

Sagent Pharmaceuticals Gross Profit Margin Quarterly Chart

    Sagent Pharmaceuticals Historical Gross Profit Margin Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 30.66%
    Dec. 31, 2012 21.83%
    Sept. 30, 2012 14.61%
    June 30, 2012 15.24%
    March 31, 2012 15.05%
    Dec. 31, 2011 9.26%
    Sept. 30, 2011 16.80%
       
    June 30, 2011 8.52%
    March 31, 2011 15.12%
    Dec. 31, 2010 18.21%
    Sept. 30, 2010 12.85%
    June 30, 2010 -0.93%
    March 31, 2010 3.39%
    Dec. 31, 2009 -3.57%

    About Gross Profit Margin

    A gross profit margin is the difference between sales and the cost of goods sold divided by revenue. This represents the percentage of each dollar of a company's revenue available after accounting for cost of goods sold.

    If a company produces phones and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32M - $24M) / $32M = 25 percent.

    Cutting costs result in higher gross profit margins. If a company sells phones for 500 dollars and the cost of the producing the phone is $250, the current gross profit margin is 50 percent ((500-250)/500). If the company is able to reduce production costs from $250 to $200, the gross profit margin is 60 percent ((500-200)/500).

    Note : Profit margins are very dependent on sector. Companies that sell bland potato chips may not have very high margins, but will sell a sizable quantity of potato chips. A company that sells consulting services will likely have higher profit margins, but sell lower quantities.
    Learn More

    Get data for

    SGNT Gross Profit Margin Quarterly Benchmarks

    Companies
    Teva Pharmaceutical Industries 52.85%
    Acura Pharmaceuticals
    Horizon Pharma 41.74%

    SGNT Gross Profit Margin Quarterly Rankings

    Overall 68th percentile
    2508 of 8006
    Sector 48th percentile
    353 of 686 in Healthcare
    Industry 42nd percentile
    39 of 68 in Drug Manufacturers - Specialty & Generic

    SGNT Gross Profit Margin Quarterly Range, Past 5 Years

    Minimum -3.57% Dec 2009
    Maximum 30.66% Mar 2013
    Average 12.65%